Objectives

With a strong academic cooperation the EUTOS 2016 program targets on:

• The application of quality controlled and standardized molecular monitoring and mutational analyses using standardized RQ-PCR technologies and an international definition of molecular results, in particular of deep molecular remission, and further expand the validation of laboratory measuring BCR-ABL according to International Scale;

• The Continuation of the EUREKA Registry, to collect data on the feasibility of the assessment of deep molecular responses in the context of real life clinical practice;

• The implementation of new molecular methods to evaluate response dynamics of CML treatment in particular of persisting stem cells;

• The evaluation of immune mechanisms in CML, in particular for the maintenance of molecular response; promotion of research among hematologists and scientists across Europe with the objective of moving along the path to cure in CML.